Tethys BioScience

Emeryville, United States Founded: 2002 • Age: 24 yrs
Develops biological markers for medical diagnostic applications.
Request Access

About Tethys BioScience

Tethys BioScience is a company based in Emeryville (United States) founded in 2002. It operates as a B2B. Tethys BioScience has raised $53.3 million across 5 funding rounds from investors including SVB, Kleiner Perkins and Oxford Finance. The company has 81 employees as of December 31, 2022. Tethys BioScience has completed 1 acquisition, including Lipomics. Tethys BioScience operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others.

  • Headquarter Emeryville, United States
  • Employees 81 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Tethys Bioscience, Inc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $53.3 M (USD)

    in 5 rounds

  • Latest Funding Round
    $23 M (USD), Series D

    Jul 21, 2010

  • Investors
    SVB

    & 8 more

  • Employee Count
    81

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Tethys BioScience
Headcount 50-200
Employee Profiles 5
Employee Profiles
People
Cathi Dall
Medical Billing Specialist

Unlock access to complete

Funding Insights of Tethys BioScience

Tethys BioScience has successfully raised a total of $53.3M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series D — $23.0M
  • First Round

    (01 Jun 2005)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2010 Amount Debt – Conventional - Tethys BioScience Valuation

investors

Jul, 2010 Amount Series D - Tethys BioScience Valuation Greenspring Associates , Paul Capital
Nov, 2009 Amount Series D - Tethys BioScience Valuation Calibrium
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Tethys BioScience

Tethys BioScience has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Kleiner Perkins and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture debt firm focused on the life sciences sector
Founded Year Domain Location
Diversified investment management firm
Founded Year Domain Location
Investment in technology startups focusing on compute, AI, and related innovations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Tethys BioScience

Tethys BioScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lipomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Diagnostics for metabolic, cardiovascular, and inflammatory conditions are developed.
2000
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Tethys BioScience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tethys Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Tethys BioScience

Tethys BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
domain founded_year HQ Location
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
domain founded_year HQ Location
In vitro diagnostic test for Gestational Diabetes Mellitus (GDM)
domain founded_year HQ Location
Proprietary protein engineering technology is developed for diabetes products.
domain founded_year HQ Location
Offers biomarker screening solutions for early diabetes detection.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tethys Bioscience

Frequently Asked Questions about Tethys BioScience

When was Tethys BioScience founded?

Tethys BioScience was founded in 2002 and raised its 1st funding round 3 years after it was founded.

Where is Tethys BioScience located?

Tethys BioScience is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.

Is Tethys BioScience a funded company?

Tethys BioScience is a funded company, having raised a total of $53.3M across 5 funding rounds to date. The company's 1st funding round was a Series D of $25M, raised on Jun 01, 2005.

How many employees does Tethys BioScience have?

As of Dec 31, 2022, the latest employee count at Tethys BioScience is 81.

What does Tethys BioScience do?

Tethys BioScience develops biological markers for medical diagnostic applications through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and biomarkers. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Who are the top competitors of Tethys BioScience?

Tethys BioScience's top competitors include Viome Life Sciences, Proteomics International and Mellitus.

How many acquisitions has Tethys BioScience made?

Tethys BioScience has made 1 acquisition, including Lipomics.

Who are Tethys BioScience's investors?

Tethys BioScience has 9 investors. Key investors include SVB, Kleiner Perkins, Oxford Finance, Greenspring Associates, and Paul Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available